Rivaroxaban Precision Dosing Strategy for Real‐World Atrial Fibrillation Patients

Rivaroxaban is a direct‐acting oral anticoagulant approved to prevent strokes in patients with atrial fibrillation. Dosage recommendations are approved for all adult patients to receive either 15 mg or 20 mg once daily depending upon renal function. There are a number of reasons to believe rivaroxab...

Descripción completa

Detalles Bibliográficos
Autores principales: Konicki, Robyn, Weiner, Daniel, Herbert Patterson, J., Gonzalez, Daniel, Kashuba, Angela, Cao, Yanguang Carter, Gehi, Anil K., Watkins, Paul, Powell, J. Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359950/
https://www.ncbi.nlm.nih.gov/pubmed/32267996
http://dx.doi.org/10.1111/cts.12766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359950/
https://www.ncbi.nlm.nih.gov/pubmed/32267996
http://dx.doi.org/10.1111/cts.12766

Ejemplares similares